Skip to content
Disclosery

EXANE DERIVATIVES: IXJ position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on IXJ, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 2,581 IXJ shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 2,581 shares
    Change vs previous 13F 0 shares

    0.12% of the 13F portfolio, value $209,380.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 2,581 shares
    Change vs previous 13F +28 shares

    0.06% of the 13F portfolio, value $226,133.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 2,553 shares
    Change vs previous 13F -88 shares

    0.06% of the 13F portfolio, value $230,630.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 2,641 shares
    Change vs previous 13F +202 shares

    0.06% of the 13F portfolio, value $221,123.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 2,439 shares
    Change vs previous 13F +332 shares

    0.05% of the 13F portfolio, value $206,505.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 2,107 shares
    Change vs previous 13F 0 shares

    0.05% of the 13F portfolio, value $162,358.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 2,107 shares
    Change vs previous 13F -119 shares

    0.05% of the 13F portfolio, value $161,073.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2020-09-30
    13F/A 2,226 shares
    Change vs previous 13F not available

    0.05% of the 13F portfolio, value $159,862.

    13F-HR/A 0001623883-20-000010 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).